Parallax Volatility Advisers, L.P. Arbutus Biopharma Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $82,680 - $144,144	31,200 New	31,200 $134,000
Q1 2019 May 15, 2019	SELL	$3.41 - $4.57 $102,300 - $137,100	-30,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.5 - $9.66 $70,000 - $193,200	-20,000 Reduced 40.0%	30,000 $115,000
Q3 2018 Nov 14, 2018	SELL	$7.85 - $12.35 $392,500 - $617,500	-50,000 Reduced 50.0%	50,000 $472,000
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $500,000 - $735,000	100,000 New	100,000 $730,000

138

95.4M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $591M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.